Key Takeaways
- Jord BioScience’s microbial seed treatments increased soybean yields by up to 3.1 bushels per acre across 16 field trial sites.
- Trials were conducted over two years under contrasting weather conditions, including drought and excessive moisture.
- The company’s microbial leads outperformed industry standards by 11% to 25%, with win-rates exceeding 80%.
- Jord leverages a global microbial bank and predictive analytics to accelerate biological discovery.
- The platform supports commercialization through partnerships and custom product development.
Jord BioScience Demonstrates Consistent Yield Improvement in Field Trials
Jord BioScience, a science and analytics company focused on customizable microbial solutions for agriculture, has announced the results of two years of replicated field trials demonstrating significant yield improvements in soybeans.
The trials, conducted at 16 locations across Iowa, Minnesota, South Dakota, and Illinois, showed that Jord’s microbial leads integrated into standard commercial soybean seed treatments delivered 1.4 to 3.1 bushels per acre of additional yield, even under highly variable seasonal conditions.
The results mark a step forward in the reliability and effectiveness of biological inputs, an area where many solutions have previously struggled to demonstrate consistent returns.
Microbial Leads Outperform Benchmarks with High Consistency
Jord’s field-tested microbial solutions outperformed leading biological and chemical seed treatments by 11% to 25% in yield outcomes. The company’s microbial leads achieved win-rates exceeding 80%, a key indicator of performance consistency across varied environments.
Andrea Arias, Vice President of Data Science and Crop Testing at Jord BioScience, commented: “In two drastically different growing seasons, our microbial leads consistently delivered yield improvements and high win rates—even in high-yield environments where biologicals rarely show ROI. This consistency is a game-changer for growers seeking reliable biological crop protection.”
Jord attributes its success to understanding microbial interactions in the soil rather than treating microbes as uniform additives. This approach enables biologically synergistic solutions that complement the existing soil ecosystem.
Accelerated Discovery Pipeline for Agricultural Biologicals
Jord BioScience leverages a 6,500-isolate global microbial bank and a predictive analytics platform to identify and validate microbial candidates quickly.
According to Dr. Keri Carstens, President and CEO of Jord BioScience: “Our field data show that our microbial leads not only outperform current benchmarks but also provide much-needed reliability for farmers seeking sustainable, high-performing crop inputs.”
Jord’s development timeline illustrates the platform’s speed. After setting a performance target in December 2022, the team identified five microbial leads for field trials by March 2023.
The company integrates regulatory and fermentation screening into the early stages of its discovery process to ensure product scalability and compliance from the outset.
Commercialization Pathways and Partnering Opportunities For Jord BioScience
Jord BioScience offers multiple commercialization models:
- Enhancing existing seed treatments or biologicals in the market
- Partnering with pipeline products to boost consistency and performance
- Developing entirely new microbials with novel modes of action
The company is positioned to collaborate with agricultural input manufacturers and seed companies to expand adoption of microbial solutions and support longer product lifecycles in a changing regulatory and climate environment.
